Wandl U - Search Results

1

[Cardiac side effects of 5-fluorouracil].

May D, Wandl U, Becher R, Niederle N, Schmidt CG. May D, et al. Among authors: wandl u. Dtsch Med Wochenschr. 1990 Apr 20;115(16):618-21. doi: 10.1055/s-2008-1065055. Dtsch Med Wochenschr. 1990. PMID: 2328669 German.

2

Ifosfamide, methotrexate and 5-fluorouracil for pretreated advanced breast cancer.

Becher R, Höfeler H, Kloke O, May D, Wandl U, Niederle N, Richter R, Scheulen ME, Schmidt CG. Becher R, et al. Among authors: wandl u. Oncology. 1991;48(6):459-63. doi: 10.1159/000226981. Oncology. 1991. PMID: 1749582

3

Ifosfamide, methotrexate, and 5-fluorouracil in advanced pretreated breast cancer.

Becher R, Höfeler H, Kloke O, Kurschel E, Schilcher RB, Weinhardt O, Wandl U, Schmidt CG. Becher R, et al. Among authors: wandl u. Semin Oncol. 1989 Feb;16(1 Suppl 3):56-9. Semin Oncol. 1989. PMID: 2495568

4

[Therapy of primary resistant or recurrent small cell bronchial carcinoma with vindesine and ifosfamide].

Höfeler H, Höffken K, Niederle N, Schoetensack B, Wandl U, Kath R, Müller M, Schmidt CG. Höfeler H, et al. Among authors: wandl u. Dtsch Med Wochenschr. 1986 Dec 19;111(51-52):1961-6. doi: 10.1055/s-2008-1068743. Dtsch Med Wochenschr. 1986. PMID: 3024948 German.

5

[The dose of alpha interferon in induction and maintainance therapy of hairy cell leukemia].

Kloke O, May D, Wandl U, Niederle N. Kloke O, et al. Among authors: wandl u. Onkologie. 1988;11 Suppl 2:41-5. doi: 10.1159/000216578. Onkologie. 1988. PMID: 3065687 Clinical Trial. German.

6

5-Fluorouracil and 5-formyltetrahydrofolate in advanced malignancies.

Becher R, Kurschel E, Wandl U, Kloke O, Scheulen M, Weinhardt O, Höffken K, Niederle N, Khan H, Bergner S, et al. Becher R, et al. Among authors: wandl u. Adv Exp Med Biol. 1988;244:225-32. doi: 10.1007/978-1-4684-5607-3_24. Adv Exp Med Biol. 1988. PMID: 3073657 Clinical Trial. No abstract available.

7

The concept of dose intensification in the treatment of neoplastic disease.

Wandl UB, Niederle N. Wandl UB, et al. Infection. 1992;20 Suppl 2:S107-10. doi: 10.1007/BF01705028. Infection. 1992. PMID: 1493934 Review.

8

The role of ifosfamide in the treatment of nonseminomatous testicular cancer.

Scheulen ME, Niederle N, Kath R, Wandl UB, Seeber S, Schmidt CG. Scheulen ME, et al. Among authors: wandl ub. Prog Clin Biol Res. 1988;269:439-50. Prog Clin Biol Res. 1988. PMID: 2455912 Review. No abstract available.

9

Phase II study of high-dose medroxyprogesterone acetate in advanced malignant melanoma.

Becher R, Kloke O, Höffken K, Scheulen ME, Wandl UB, Bojar H, Schmidt CG. Becher R, et al. Among authors: wandl ub. Br J Cancer. 1989 Jun;59(6):948. doi: 10.1038/bjc.1989.201. Br J Cancer. 1989. PMID: 2525403 Free PMC article. No abstract available.

10

A prospective randomized comparison of single-agent interferon (IFN)-alpha with the combination of IFN-alpha and low-dose IFN-gamma in chronic myelogenous leukaemia.

Kloke O, Wandl U, Opalka B, Moritz T, Nagel-Hiemke M, Franz T, Becher R, Hirche H, Seeber S, Niederle N. Kloke O, et al. Among authors: wandl u. Eur J Haematol. 1992 Feb;48(2):93-8. doi: 10.1111/j.1600-0609.1992.tb00572.x. Eur J Haematol. 1992. PMID: 1547881 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

49 results

Search Page

Filters